XPhyto Therapeutics is a science-based company focusing on medical formulation, clinical validation, and emerging European markets.
Their 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH has been granted a unique German cultivation and extraction licence for scientific purposes.
In addition, XPhyto Laboratories Inc., is a wholly owned subsidiary of XPhyto Therapeutics Corp. In general, they provide certified third party analytical testing (cannabinoids, heavy metals, pesticides, etc.) to Canadian licenced growers, processors, dispensaries, and government agencies.
XPhyto Therapeutics Corp. (XPHY:CSE)
Subscribe to receive more investment opportunities videos: http://bit.ly/Subscribe2BTV
Check out more videos:
Business TV episodes: http://bit.ly/2UBerea
CEO Clips: http://bit.ly/2UTdumA
New Listing Alert: http://bit.ly/2W1o0ob